Compare Stocks: PRCT, ITGR, IRTC, and PLSE

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IRTC iRhythm Technologies	$135.18 +7.0%	$115.02	$100.70 ▼ $192.47	$4.46B	1.39	593,124 shs	852,965 shs
ITGR Integer	$126.73 +0.1%	$126.29	$66.00 ▼ $126.83	$4.31B	0.6	783,003 shs	388,019 shs
PLSE Pulse Biosciences	$57.01 +9.2%	$51.19	$12.56 ▼ $58.90	$4.04B	1.65	389,189 shs	323,596 shs
PRCT PROCEPT BioRobotics	$21.91 +8.6%	$19.33	$16.67 ▼ $38.11	$1.26B	0.88	1.50 million shs	1.70 million shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IRTC iRhythm Technologies	+0.16%	+2.12%	+14.50%	+1.50%	-31.69%
ITGR Integer	+0.02%	-0.02%	+0.11%	+1.34%	+89.38%
PLSE Pulse Biosciences	-1.32%	-1.88%	+8.98%	+37.73%	+210.90%
PRCT PROCEPT BioRobotics	+3.76%	+1.87%	+17.54%	+4.29%	-41.55%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IRTC iRhythm Technologies	$135.18 +7.0%	$115.02	$100.70 ▼ $192.47	$4.46B	1.39	593,124 shs	852,965 shs
ITGR Integer	$126.73 +0.1%	$126.29	$66.00 ▼ $126.83	$4.31B	0.6	783,003 shs	388,019 shs
PLSE Pulse Biosciences	$57.01 +9.2%	$51.19	$12.56 ▼ $58.90	$4.04B	1.65	389,189 shs	323,596 shs
PRCT PROCEPT BioRobotics	$21.91 +8.6%	$19.33	$16.67 ▼ $38.11	$1.26B	0.88	1.50 million shs	1.70 million shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IRTC iRhythm Technologies	+0.16%	+2.12%	+14.50%	+1.50%	-31.69%
ITGR Integer	+0.02%	-0.02%	+0.11%	+1.34%	+89.38%
PLSE Pulse Biosciences	-1.32%	-1.88%	+8.98%	+37.73%	+210.90%
PRCT PROCEPT BioRobotics	+3.76%	+1.87%	+17.54%	+4.29%	-41.55%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IRTC iRhythm Technologies	2.94	Moderate Buy	$174.50	28.19% Upside
ITGR Integer	2.08	Hold	$113.67	-10.30% Downside
PLSE Pulse Biosciences	2.86	Moderate Buy	$60.20	8.73% Upside
PRCT PROCEPT BioRobotics	2.38	Hold	$25.50	10.73% Upside

Current Analyst Ratings Breakdown

Latest PRCT, ITGR, IRTC, and PLSE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/27/2026	IRTC iRhythm Technologies	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
10/23/2026	ITGR Integer	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C) ➝ Hold (C+)
10/16/2026	IRTC iRhythm Technologies	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Overweight	$160.00
10/16/2026	PRCT PROCEPT BioRobotics	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong-Buy
10/15/2026	PLSE Pulse Biosciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/15/2026	PRCT PROCEPT BioRobotics	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
10/13/2026	PLSE Pulse Biosciences	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$55.00
10/13/2026	PLSE Pulse Biosciences	Oppenheimer Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Outperform	$35.00 ➝ $60.00
10/12/2026	IRTC iRhythm Technologies	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
10/6/2026	PRCT PROCEPT BioRobotics	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Overweight	$30.00
10/6/2026	PLSE Pulse Biosciences	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$43.00 ➝ $58.00

(Data available from 11/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IRTC iRhythm Technologies	$747.14M	6.01	N/A	N/A	$4.74 per share	28.72
ITGR Integer	$1.85B	2.32	$10.38 per share	12.21	$50.78 per share	2.50
PLSE Pulse Biosciences	$350K	11,199.55	N/A	N/A	$1.19 per share	46.53
PRCT PROCEPT BioRobotics	$308.05M	4.28	N/A	N/A	$6.55 per share	3.52

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IRTC iRhythm Technologies	-$44.55M	-$0.43	N/A	99.36	N/A	-1.69%	10.11%	1.53%	11/5/2026 (Estimated)
ITGR Integer	$102.81M	$2.98	42.53	18.89	2.41	5.68%	11.84%	5.98%	N/A
PLSE Pulse Biosciences	-$72.78M	-$1.18	N/A	N/A	N/A	-6,755.78%	-94.42%	-79.96%	11/5/2026 (Confirmed)
PRCT PROCEPT BioRobotics	-$95.57M	-$1.94	N/A	N/A	N/A	-32.53%	-30.62%	-22.10%	11/4/2026 (Estimated)

Latest PRCT, ITGR, IRTC, and PLSE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	IRTC iRhythm Technologies	$0.0155	N/A	N/A	N/A	$222.23 million	N/A
11/5/2026	Q3 2026	PLSE Pulse Biosciences	-$0.3095	N/A	N/A	N/A	$0.52 million	N/A
11/4/2026	Q3 2026	PRCT PROCEPT BioRobotics	-$0.3915	N/A	N/A	N/A	$100.52 million	N/A
10/29/2026	Q3 2026	ITGR Integer	$1.68	$1.34	-$0.34	$0.43	$456.91 million	$449.66 million
8/6/2026	Q2 2026	IRTC iRhythm Technologies	-$0.04	$0.58	+$0.62	-$0.01	$219.30 million	$224.17 million
8/6/2026	Q2 2026	PLSE Pulse Biosciences	-$0.2933	-$0.36	-$0.0667	-$0.36	$0.53 million	$0.43 million
8/4/2026	Q2 2026	PRCT PROCEPT BioRobotics	-$0.4619	-$0.47	-$0.0081	-$0.47	$92.77 million	$94.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
IRTC iRhythm Technologies	N/A	N/A	N/A	N/A	N/A
ITGR Integer	N/A	N/A	N/A	N/A	N/A
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IRTC iRhythm Technologies	3.50	3.86	3.74
ITGR Integer	0.73	3.98	2.60
PLSE Pulse Biosciences	N/A	9.63	9.61
PRCT PROCEPT BioRobotics	0.15	6.55	5.35

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IRTC iRhythm Technologies	N/A
ITGR Integer	99.29%
PLSE Pulse Biosciences	76.95%
PRCT PROCEPT BioRobotics	89.46%

Insider Ownership

Company	Insider Ownership
IRTC iRhythm Technologies	0.98%
ITGR Integer	1.10%
PLSE Pulse Biosciences	74.00%
PRCT PROCEPT BioRobotics	4.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IRTC iRhythm Technologies	2,400	32.96 million	32.64 million	Optionable
ITGR Integer	11,000	34.00 million	33.62 million	Optionable
PLSE Pulse Biosciences	116	70.80 million	18.41 million	Optionable
PRCT PROCEPT BioRobotics	888	57.27 million	54.98 million	Optionable

PRCT, ITGR, IRTC, and PLSE Headlines

Recent News About These Companies

Earnings To Watch: PROCEPT BioRobotics Corp (PRCT) Q3 2026 -- GF Value Sees 471% Upside

November 3 at 3:27 PM | finance.yahoo.com

PROCEPT BioRobotics (NASDAQ:PRCT) Share Price Crosses Above 50 Day Moving Average - What's Next?

November 3 at 5:19 AM | marketbeat.com

PROCEPT BioRobotics (PRCT) Set to Announce Earnings on Wednesday

November 3 at 2:43 AM | americanbankingnews.com

PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

October 28, 2026 | zacks.com

PROCEPT BioRobotics (PRCT) Set to Release Quarterly Earnings on Wednesday

October 28, 2026 | marketbeat.com

PROCEPT BioRobotics (PRCT) Stock May Be Fully Priced On Cash Flow Hopes

October 25, 2026 | uk.finance.yahoo.com

PROCEPT BioRobotics: Compelling Bet On Aquablation's Growth

October 22, 2026 | seekingalpha.com

PROCEPT BioRobotics (NASDAQ:PRCT) Shares Climb 7.6% - Time to Buy?

October 22, 2026 | marketbeat.com

PROCEPT BioRobotics Corp (PRCT) Shares Surge 4.0% -- What GF Score of 71 Tells Investors

October 19, 2026 | gurufocus.com

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Stock Now Rated "Hold" by Wall Street Analysts

October 15, 2026 | marketbeat.com

Leerink Partners Sticks to Their Hold Rating for PROCEPT BioRobotics (PRCT)

October 14, 2026 | theglobeandmail.com

Barclays initiates coverage of PROCEPT BioRobotics at overweight

October 12, 2026 | msn.com

PROCEPT BioRobotics Corporation to Report Third Quarter 2026 Financial Results on November 4, 2026

October 12, 2026 | quiverquant.comQ

PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026

October 12, 2026 | globenewswire.com

PROCEPT BioRobotics (NASDAQ:PRCT) Upgraded at Barclays

October 9, 2026 | marketbeat.com

PROCEPT BioRobotics stock fell 1.74 percent on October 6

October 8, 2026 | ad-hoc-news.deA

PROCEPT BioRobotics (PRCT) Could Be 70% Undervalued On Lawsuit And Board Change

October 8, 2026 | finance.yahoo.com

Barclays initiates coverage of PROCEPT BioRobotics with overweight rating

October 7, 2026 | msn.com

Barclays Initiates PROCEPT BioRobotics at Overweight With $30 Price Target

October 7, 2026 | marketscreener.comM

PROCEPT BioRobotics (NASDAQ:PRCT) Shares Up 4.3% - Still a Buy?

October 7, 2026 | marketbeat.com

Does New Director and Discounting Lawsuit Change The Bull Case For PROCEPT BioRobotics (PRCT)?

October 6, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT, ITGR, IRTC, and PLSE Company Descriptions

iRhythm Technologies NASDAQ:IRTC

$134.30 +7.93 (+6.27%)

As of 03:47 PM Eastern

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Integer NYSE:ITGR

$126.72 +0.17 (+0.13%)

As of 03:46 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Pulse Biosciences NASDAQ:PLSE

$56.74 +4.54 (+8.69%)

As of 03:47 PM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

PROCEPT BioRobotics NASDAQ:PRCT

$21.76 +1.60 (+7.91%)

As of 03:47 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PRCT, ITGR, IRTC, and PLSE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PRCT, ITGR, IRTC, and PLSE Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PRCT, ITGR, IRTC, and PLSE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT, ITGR, IRTC, and PLSE Company Descriptions

iRhythm Technologies NASDAQ:IRTC

Integer NYSE:ITGR

Pulse Biosciences NASDAQ:PLSE

PROCEPT BioRobotics NASDAQ:PRCT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PRCT, ITGR, IRTC, and PLSE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PRCT, ITGR, IRTC, and PLSE Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PRCT, ITGR, IRTC, and PLSE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT, ITGR, IRTC, and PLSE Company Descriptions

iRhythm Technologies NASDAQ:IRTC

Integer NYSE:ITGR

Pulse Biosciences NASDAQ:PLSE

PROCEPT BioRobotics NASDAQ:PRCT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools